Monashee Investment Management

Founded -

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Average round size
info
The average size of a deal this fund participated in
$176M
Portfolio companies 7
Lead investments 0
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Health Diagnostics

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bedrock Capital United States, New York
New York Venture Partners United States, New York
Calumet Venture Fund United States, Madison
SUNeVision Ventures China, Hong Kong Island
Phoenix Fund China, Beijing
Friends Ivory & Sime -
Backcast Partners United States, New York
Darsana Capital Partners United States, New York
Wuhan Haizhida Keji Touzi Youxian Gongsi China, Wuhan
Savage Partners United States, West Palm Beach
Federal Street Angels -
Toread Holdings Group China, Changping
Yanlingxian Qianqian Shangmao China, Henan
Reliance Life Insurance India, Mumbai
Zhuhai Qirong Venture Capital Management China, Zhuhai
Foton Daimler Automotive China, Huairou
Suzhou Decheng Hongxing Touzi China, Suzhou
China-ASEAN etst Investment Cooperation Fund China, Hong Kong Island
Friends Ivory & Sime -
Colgate Entrepreneurs Fund United States, Hamilton
Hwabao Trust China, Beijing

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

HiberCell

Biotechnology
Health Care
Health Diagnostics
Medical
1
$67M19 May 2021 United States, New York

1
$250M14 Apr 2021

X4 Pharmaceuticals

Biotechnology
Clinical Trials
Health Care
Pharmaceutical
Therapeutics
1
$55M19 Mar 2021 United States, Cambridge

Caribou Biosciences

Biotechnology
Health Care
Therapeutics
1
$115M03 Mar 2021 United States, Berkeley

EGenesis

Biopharma
Biotechnology
Genetics
Life Science
Medical
1
$125M02 Mar 2021 United States, Cambridge

Nuvation Bio

Biotechnology
Pharmaceutical
1
$502M11 Feb 2021 United States, New York

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
1
$121M25 Nov 2020 United States, Boulder
News
Garuda Therapeutics Raises $72M in Series A Financing

– Garuda Therapeutics from Cambridge develops off-the-shelf, durable blood stem cell therapies.
– Series A funding of $72m brings company valuation to more than $1b.
– The round was led by Aisling Capital, Northpond Ventures and Orbimed, supported by Cormorant Asset Management, Ridgeback Capital Investments, Monashee Investment Management, Sectoral Asset Management, National Resilience, Inc. (Resilience), Mass General Brigham Ventures, among others.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Monashee Investment Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: